1. "Hematologic Malignancies Service"
Formats
  1. Journal Article (349)
  2. Meeting Abstract (232)
  3. Review (11)
  4. Research Letter (5)
  5. Editorial (4)
  6. Book Section (2)
  7. Conference Paper (2)
  8. Correspondence (1)
  9. Guidelines (1)
Groups
  1. Hematologic Malignancies Service (607)
  2. Pediatrics, Department of (607)
  3. Center for Hematologic Malignancies (554)
  4. Pediatric Leukemia (455)
  5. GSK Faculty (220)
  6. Tow Center for Developmental Oncology (TCDO) (206)

More Groups

People
  1. Peter Steinherz (221)
  2. Neerav Shukla (159)
  3. Tanya Trippett (126)
  4. Alex Kentsis (103)
  5. Christopher Forlenza (49)
  6. Marc Ladanyi (44)

More People

Years
  1. 2025 (11)
  2. 2024 (27)
  3. 2023 (37)
  4. 2022 (34)
  5. 2021 (29)
  6. 2020 (29)

More Years

Publications
  1. Blood (125)
  2. Journal of Clinical Oncology (61)
  3. Pediatric Blood and Cancer (57)
  4. Cancer Research (22)
  5. Cancer (18)
  6. Journal of Pediatric Hematology/Oncology (16)

More Publications

Publishers
  1. American Society of Hematology (134)
  2. American Society of Clinical Oncology (69)
  3. Wiley Periodicals, Inc (57)
  4. American Association for Cancer Research (56)
  5. Nature Publishing Group (39)
  6. Elsevier Inc. (33)

More Publishers

Results (607)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MYB mimic peptides targeting human and murine MYB-NFIB positive tumor cells
    Meeting Abstract

    Jiang, Y.; Forbes, L.; Li, J.; Freeberg, S.; Cao, C.; Zajac-Kaye, M.; Licht, J.; Kentsis, A.; Kaye, F.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase I and expanded access experience of LOXO-195 (BAY 2731954), a selective next-generation TRK inhibitor (TRKi)
    Meeting Abstract

    Hyman, D.; Kummar, S.; Farago, A.; Geoerger, B.; Mau-Sorensen, M.; Taylor, M.; Garralda, E.; Nagasubramanian, R.; Natheson, M.; Song, L.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia
    Meeting Abstract

    McNeer, N.; Philip, J.; Geiger, H.; Ries, R. E.; Lavallee, V. P.; Walsh, M.; Shah, M.; Arora, K.; Emde, A. K.; Robine, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Correlation between response to atezolizumab and PD-L1 tumor expression in pediatric and young adult patients enrolled in the phase I/II iMATRIX-atezo study
    Meeting Abstract

    Hutchinson, K. E.; Liao, M.; Farid-Kapadia, M.; Donaldson, F.; Tam, N. W. R.; Fu, L. H.; Das Thakur, M.; Zwaan, C. M.; Geoerger, B.; Marshall, L. V.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma
    Journal Article

    Jiang, Y.; Gao, R.; Cao, C.; Forbes, L.; Li, J.; Freeberg, S.; Fredenburg, K. M.; Justice, J. M.; Silver, N. L.; Wu, L.; more...
    Oral Oncology (2019)

    Fulltext@MSK | Save
  • Treatment of higher risk acute lymphoblastic leukemia in young people (CCG-1961), long-term follow-up: A report from the Children’s Oncology Group
    Journal Article

    Steinherz, P. G.; Seibel, N. L.; Sather, H.; Ji, L.; Xu, X.; Devidas, M.; Gaynon, P. S.
    Leukemia (2019)

    Fulltext@MSK | Save
  • Activity of larotrectinib, a highly selective inhibitor of tropomyosin receptor kinase, in TRK fusion breast cancers
    Meeting Abstract

    Meric-Bernstam, F.; Shukla, N.; Peled, N.; Landman, Y.; Onitilo, A.; Montez, S.; Ku, N. C.; Hyman, D. M.; Drilon, A.; Hong, D. S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms’ tumor
    Journal Article

    Ortiz, M. V.; Ahmed, S.; Burns, M.; Henssen, A. G.; Hollmann, T. J.; MacArthur, I.; Gunasekera, S.; Gaewsky, L.; Bradwin, G.; Ryan, J.; more...
    JCI Insight (2019)

    Fulltext@MSK | Save
  • Prohibitin promotes dedifferentiation and is a potential therapeutic target in neuroblastoma
    Journal Article

    MacArthur, I. C.; Bei, Y.; Garcia, H. D.; Ortiz, M. V.; Toedling, J.; Klironomos, F.; Rolff, J.; Eggert, A.; Schulte, J. H.; Kentsis, A.; more...
    JCI Insight (2019)

    Fulltext@MSK | Save
  • A cancer-associated missense mutation in PP2A-Aα increases centrosome clustering during mitosis
    Journal Article

    Antao, N. V.; Marcet-Ortega, M.; Cifani, P.; Kentsis, A.; Foley, E. A.
    iScience (2019)

    Fulltext@MSK | Save